Developed SARS-CoV-2 vaccines face threats from the emergence and rapid spread of viral variants, it induced immunity by its prototype S protein, which exhibited wane over time, thus decreasing protection against COVID-19 [42–44]. This evidence concerns the gene PROS1 and COVID-19.